首页> 外文期刊>Toxicology: An International Journal Concerned with the Effects of Chemicals on Living Systems >New beta-adrenergic agonists used illicitly as growth promoters in animal breeding: chemical and pharmacodynamic studies.
【24h】

New beta-adrenergic agonists used illicitly as growth promoters in animal breeding: chemical and pharmacodynamic studies.

机译:新型β-肾上腺素能激动剂在动物育种中被非法用作生长促进剂:化学和药效学研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Clenbuterol and beta-adrenergic receptor agonist drugs are illegally used as growth promoters in animal production. Pharmacologically active residues in edible tissues led to intoxication outbreaks in several countries. Pressure of official controls pulsed synthesis of new compounds to escape analytical procedures. We report two new compounds named 'A' and 'G4', found in feeding stuffs. Chemical structure was studied through nuclear magnetic resonance-imaging and infrared spectroscopy, and beta(1)- and beta(2)-adrenergic activity was evaluated on isolated guinea-pig atrium and trachea in comparison with clenbuterol. Both compounds share with clenbuterol an halogenated aromatic ring with a primary amino group. Main modifications consisted of substitution of secondary amino group with an alkyl chain in compound A and substitution of the ter-butyl group with a benzene ring in compound G4. In guinea-pig trachea these compounds showed myorelaxant potency lower than clenbuterol (EC(50) was 43.8 nM for clenbuterol, 11700 nM for compound A, 2140 nM for G4). On the contrary, in the guinea-pig atrium (heart-beat rate stimulant effect) the compounds were more potent than clenbuterol (EC(50) was 15.2 nM for clenbuterol, 3.4 nM for compound A, 2.8 nM for G4). These pharmacodynamic properties, and stronger lipophilic properties shown by the two compounds may result in increased cardiovascular risk for consumers of illicitly treated animals.
机译:瘦肉精和β-肾上腺素能受体激动剂药物被非法用作动物生产中的生长促进剂。可食用组织中的药理活性残留物导致一些国家爆发中毒事件。官方控制部门的压力是通过脉冲合成新化合物来逃脱分析程序。我们报告了在饲料中发现的两种新化合物“ A”和“ G4”。化学结构通过核磁共振成像和红外光谱进行了研究,并比较了克仑特罗对豚鼠心房和气管的β(1)-和β(2)-肾上腺素能活性进行了评估。两种化合物均与盐酸克伦特罗共享具有伯氨基的卤代芳族环。主要的修饰包括在化合物A中用烷基链取代仲氨基,在化合物G4中用苯环取代叔丁基。在豚鼠气管中,这些化合物的肌肉松弛药效力低于克仑特罗(EC(50)克仑特罗为43.8 nM,化合物A为11700 nM,G4为2140 nM)。相反,在豚鼠心房(心跳速率刺激作用)中,这些化合物比克仑特罗更有效(克仑特罗EC(50)为15.2 nM,化合物A为3.4 nM,G4为2.8 nM)。这两种化合物显示出的这些药效特性和更强的亲脂性可能导致非法治疗动物的消费者罹患心血管疾病的风险增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号